ADMA Biologics Inc share price logo

ADMA Biologics Inc

NASDAQ: ADMA

Mid Cap

$10.51

+0.26

(+2.54%)

as on

ADMA Biologics Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $10.27
    $10.56
    downward going graph

    2.28%

    Downside

    0.48%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.21
    $24.17
    downward going graph

    31.40%

    Downside

    129.97%

    Upside

    downward going graph

ADMA Biologics Inc share price movements today

Previous Close
$10.25
Open
$10.28
Volume
4.2M
Day's Low - High
$10.27 - $10.56
52 Week Low - High
$7.21 - $24.17

ADMA Biologics Inc Historical Returns

1 Month Return
+ 14.47 %
3 Month Return
-36.2 %
1 Year Return
-55.27 %
3 Year Return
+ 207.6 %
5 Year Return
0 %

ADMA Biologics Inc Stock Fundamentals & Key Indicators

Check ADMA Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

0.9533

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.53%

PE Ratio (TTM)

17.53

Industry PE ratio

-7.5

PEG Ratio

0

EBITDA

199.5M

Revenue (TTM)

510.2M

Profit Margin

28.80%

Return On Equity TTM

35.56%

ADMA Biologics Inc Stock Valuation

Track how ADMA Biologics Inc P/E has moved over time to understand its valuation trends.

ADMA Biologics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-34.99x)

September 30, 2023

Industry (-7.50x)

May 4, 2026

Today (17.53x)

May 4, 2026

Highest (59.92x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 17.53x

ADMA Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ADMA Biologics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ADMA Biologics Inc image
ADMA Biologics Inc
BUY$2.4BNA17.5328.80%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.5B125.06%74.5912.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.8B97.31%27.7132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA118.975.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B44.57%17.1229.65%

Stock Returns calculator for ADMA Biologics Inc Stock including INR - Dollar returns

The ADMA Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ADMA Biologics Inc investment value today

Current value as on today

₹50,396

Returns

-₹49,604

(-49.6%)

Returns from ADMA Biologics Inc Stock

-₹55,315 (-55.31%)

Dollar Impact

₹5,711 (+5.71%)

Analyst Recommendation on ADMA Biologics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for ADMA Biologics Inc. Average target price of $20.67

ADMA Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on ADMA Biologics Inc.

What analysts predicted

49.15%UPSIDE

Target Price

$20.67

Current Price

$10.51

Analyzed by

10 Analysts

Target

$20.67

ADMA Biologics Inc target price $20.67, a slight upside of 49.15% compared to current price of $10.51. According to 10 analysts rating.

ADMA Biologics Inc Stock’s Investor Sentiment and Interest

Search interest for ADMA Biologics Inc Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

ADMA Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
67
73
81
107
119
117
114
121
134
139
Gross Profit
24
31
39
57
59
63
61
67
75
88
Operating Income
8
14
21
39
39
38
34
42
51
62
EBITDA
11
-9
24
41
42
39
37
43
51
65
Interest Expense
6
6
3
3
3
2
1
1
1
1
Depreciation
2
2
2
2
1
1
1
2
2
2
Income Before Tax
2
-17
18
35
36
34
33
40
47
61
Income Tax Expense
6
0
0
3
0
-77
6
5
11
12
Net Income
2
-17
17
32
35
111
26
34
36
49
Net Profit Margin
3.81%
-23.88%
21.75%
29.91%
29.96%
95.19%
23.44%
28.05%
27.14%
35.48%

ADMA Biologics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
22
16
29
42
80
154
258
426
510
Gross Profit
4
-6
-25
-10
-19
1
35
88
219
292
Operating Income
-17
-39
-60
-41
-64
-58
-39
21
138
191
EBITDA
-16
-39
-56
-36
-59
-53
-39
5
147
197
Interest Expense
2
3
5
8
11
13
19
25
13
7
Depreciation
-
2
3
3
3
5
7
8
8
8
Income Before Tax
-19
-43
-65
-48
-75
-71
-65
-28
125
182
Income Tax Expense
2
4
5
8
11
12
19
8
-71
35
Net Income
-19
-43
-65
-48
-75
-71
-65
-28
197
146
Net Profit Margin
-183.05%
-192.26%
-387.06%
-164.50%
-179.41%
-88.52%
-42.77%
-10.94%
46.35%
28.80%

ADMA Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-17
17
32
35
111
26
34
36
49
Operating Cash Flow
17
-2
45
25
50
-19
21
13
35
Investing Cash Flow
-1
-2
-2
-1
-2
-4
-2
-14
0
Financing Cash Flow
-38
-1
0
-25
-31
-7
0
-27
-9
Change in Cash
-22
-6
42
-1
16
-31
18
-28
26

ADMA Biologics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-43
-65
-48
-75
-71
-65
-28
197
146
Operating Cash Flow
-37
-62
-76
-102
-112
-59
8
118
50
Investing Cash Flow
15
-2
-3
-12
-13
-13
-4
-8
-21
Financing Cash Flow
60
42
80
143
121
108
-38
-58
-44
Change in Cash
38
-21
0
29
-4
35
-35
51
-15

Global Institutional Holdings in ADMA Biologics Inc

Funds
Holdings
Geode Capital Management, LLC
2.51%
Dimensional Fund Advisors, Inc.
2.08%
Charles Schwab Investment Management Inc
0.97%
Capital Research Global Investors
1.37%
BlackRock Inc
15.34%
See all

ADMA Biologics Inc News & Key Events

  • img

    Today's Timeline - 24 March

    Tue, 08:01 PM

    -

    ADMA Biologics' 2026 EPS estimates increased from 85 cents to 96 cents, but shares have lost 11.3% over six months.

Insights on ADMA Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 26.90M → 49.37M (in $), with an average increase of 17.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 114.80M → 139.16M (in $), with an average increase of 6.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 71.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ADMA stock has moved down by -36.2%

About ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
OrganisationADMA Biologics Inc
Headquarters465 State Route 17, Ramsey, NJ, United States, 07446
IndustryBiotechnology
CEOMr. Adam S. Grossman
E-voting on sharesClick here to vote

Key Management of ADMA Biologics Inc

Name

Title

Mr. John Hafl

Executive Director of Sales

Mr. Skyler Bloom

Senior Director of Business Development & Corporate Strategy

Mr. Adam S. Grossman

Co-Founder, President, CEO & Director

Dr. Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

Mr. P. Terence Kohler

CFO & Treasurer

Ms. Kaitlin M. Kestenberg

COO & Senior VP of Compliance

Mr. Brad L. Tade

Consultant

Mr. Michael Goldstein

General Counsel

FAQs

What is ADMA Biologics Inc share price today?

ADMA Biologics Inc share price today is $10.51 as on at the close of the market. ADMA Biologics Inc share today touched a day high of $10.56 and a low of $10.27.

What is the 52 week high and 52 week low for ADMA Biologics Inc share?

ADMA Biologics Inc share touched a 52 week high of $24.17 on and a 52 week low of $7.21 on . ADMA Biologics Inc stock price today i.e. is closed at $10.51,which is 56.52% down from its 52 week high and 45.77% up from its 52 week low.

What is ADMA Biologics Inc's market capitalisation today?

ADMA Biologics Inc market capitalisation is $0.00T as on .

How to invest in ADMA Biologics Inc Stock (ADMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ADMA Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ADMA Biologics Inc Shares that will get you 0.1427 shares as per ADMA Biologics Inc share price of $10.51 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy ADMA Biologics Inc Stock (ADMA) from India?

Indian investors can start investing in ADMA Biologics Inc (ADMA) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in ADMA Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on ADMA Biologics Inc share’s latest price of $10.51 as on May 2, 2026 at 1:29 am IST, you will get 0.9515 shares of ADMA Biologics Inc. Learn more about fractional shares .